GlassScriptPhysician profile
Gail D Miller
NPI 1770502494
$745.17
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $170 · 2021: $175 · 2022: $75.80 · 2023: $20.29 · 2024: $19.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $40.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $40.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $231.30 | 2019-2022 | |
| Avion Pharmaceuticals | $90.52 | 2020-2021 | |
| Hologic Sales and Service, LLC | $87.77 | 2019-2024 | Omni Hysteroscope, Myosure Tissue Removal Device |
| Amarin Pharma, INC. | $71.78 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $54.51 | 2020 | |
| Lupin INC. | $46.23 | 2019 | |
| Therapeuticsmd, INC. | $33.30 | 2019-2021 | |
| Pfizer INC. | $20.29 | 2023 | |
| Exeltis, USA INC. | $18.01 | 2021 | |
| Ascend Therapeutics US, LLC | $18.00 | 2021 | |
| Mission Pharmacal Company | $16.93 | 2021 | |
| Boston Scientific Corporation | $16.34 | 2019 | |
| Aspira Women'S Health INC | $14.41 | 2021 | |
| Bausch Health US, LLC | $12.93 | 2021 | |
| Dysis Medical, INC. | $12.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gail Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.